Cloning, high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E

被引:14
作者
Mansour, Abdoulreza Agheli [2 ]
Mousavi, Seyed Latif [1 ]
Rasooli, Iraj [1 ]
Nazarian, Shahram [3 ]
Amani, Jafar [2 ]
Farhadi, Nima [2 ]
机构
[1] Shahed Univ, Dept Biol, Tehran 3319118651, Iran
[2] Baqiyatallah Univ Med Sci, Med Biol Res Ctr, Tehran, Iran
[3] Imam Hossein Univ, Dept Biol, Inst Basic Sci, Tehran, Iran
关键词
Botulinum neurotoxin; Immunogenicity; Synthetic gene; Binding domain; TOXIN FRAGMENT-C; CLOSTRIDIUM-BOTULINUM; BINDING DOMAIN; H-C; ESCHERICHIA-COLI; SEROTYPE-A; T-CELLS; ANTIBODIES; RECEPTOR; TETANUS;
D O I
10.1016/j.biologicals.2009.09.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins (BoNTs) inhibit neurotransmitter release from peripheral cholinergic synapses. BoNTs consist of a toxifying light chain and a heavy chain (HC) linked through a disulfide bond. In the present study we explored the immunogenicity and protective capability of the most effective part corresponding to 1163-1256 residues of botulinum type E neurotoxin HC gene. DNA encoding the 93 C-terminal amino acid of HC residues was synthesized with optimal codon usage for expression. These DNA fragments were ligated into a pLivSelect vector and subcloned into expression vector pET32a. Recombinant plasmids were then transformed into Escherichia coli strain BL21 DE3. The recombinant protein was purified by nickel affinity gel column chromatography. The HC1163-1256 was identified by antibodies raised against BoNT/E. HC1163-1256 was shown to bind with synaptotagmin and gangliosides, indicating that the expressed and purified HC1163-1256 protein retains a functionally active conformation. The immunization with recombinant protein induced a protection level in mice. The immunization with 2 mu g of the recombinant protein induced a significant protection level in mice. In conclusion, availability of the recombinant protein provides an effective system to study the biochemical and physical interactions involved during BoNT binding to nerve cells and protection against its toxicity. (C) 2009 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:260 / 264
页数:5
相关论文
共 31 条
[1]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[2]  
Atassi MZ, 1999, CRIT REV IMMUNOL, V19, P219
[3]   Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species [J].
Atassi, MZ ;
Dolimbek, BZ ;
Hayakari, M ;
Middlebrook, JL ;
Whitney, B ;
Oshima, M .
JOURNAL OF PROTEIN CHEMISTRY, 1996, 15 (07) :691-700
[4]   Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E [J].
Baldwin, MR ;
Tepp, WH ;
Pier, CL ;
Bradshaw, M ;
Ho, MF ;
Wilson, BA ;
Fritz, RB ;
Johnson, EA ;
Barbieri, JT .
INFECTION AND IMMUNITY, 2005, 73 (10) :6998-7005
[5]   Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey [J].
Boles, James ;
West, Michael ;
Montgomery, Vicki ;
Tammariello, Ralph ;
Pitt, M. Louise M. ;
Gibbs, Paul ;
Smith, Leonard ;
LeClaire, Ross D. .
TOXICON, 2006, 47 (08) :877-884
[6]   Development of vaccines for prevention of botulism [J].
Byrne, MP ;
Smith, LA .
BIOCHIMIE, 2000, 82 (9-10) :955-966
[7]   PROTECTIVE VACCINATION WITH A RECOMBINANT FRAGMENT OF CLOSTRIDIUM-BOTULINUM NEUROTOXIN SEROTYPE A EXPRESSED FROM A SYNTHETIC GENE IN ESCHERICHIA-COLI [J].
CLAYTON, MA ;
CLAYTON, JM ;
BROWN, DR ;
MIDDLEBROOK, JL .
INFECTION AND IMMUNITY, 1995, 63 (07) :2738-2742
[8]   Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum [J].
Dertzbaugh, MT ;
West, MW .
VACCINE, 1996, 14 (16) :1538-1544
[9]  
FIOCK MA, 1963, J IMMUNOL, V90, P697
[10]   Structure-based sequence alignment for the β-trefoil subdomain of the clostridial neurotoxin family provides residue level information about the putative ganglioside binding site [J].
Ginalski, K ;
Venclovas, C ;
Lesyng, B ;
Fidelis, K .
FEBS LETTERS, 2000, 482 (1-2) :119-124